Загрузка...
Novel therapies for severe asthma in children and adults
The heterogeneous nature of asthma requires personalised treatments. Monoclonal antibody treatments showed good efficacy, and should be considered when symptoms are poorly controlled despite good inhaler technique, compliance and controlled comorbidities. http://ow.ly/UWpg30hImQh
Сохранить в:
| Опубликовано в: : | Breathe (Sheff) |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
European Respiratory Society
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5831346/ https://ncbi.nlm.nih.gov/pubmed/29515670 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/20734735.018917 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|